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Abstract 
Background: A core outcome set (COS; an agreed, minimum set of outcomes) was needed 
to address the heterogeneous measurement of outcomes in aphasia treatment research and to 
facilitate the production of transparent, meaningful and efficient outcome data.  
Objective: The Research Outcome Measurement in Aphasia (ROMA) consensus statement 
provides evidence-based recommendations for the measurement of outcomes for adults with 
post-stroke aphasia within phase I-IV aphasia treatment studies. 
Methods: This statement was informed by a four-year program of research which comprised 
investigation of stakeholder-important outcomes using consensus processes, a scoping review 
of aphasia outcome measurement instruments, and an international consensus meeting.  This 
paper provides an overview of this process and presents the results and recommendations 
arising from the international consensus meeting.  
Results: Five essential outcome constructs were identified: Language, communication, 
patient-reported satisfaction with treatment and impact of treatment, emotional wellbeing, 
and quality of life. Consensus was reached for the following measurement instruments: 
Language: The Western Aphasia Battery Revised (WAB-R) (74% consensus); emotional 
well-being: General Health Questionnaire (GHQ)-12 (83% consensus); quality of life: Stroke 
and Aphasia Quality of Life Scale (SAQOL-39) (96% consensus). Consensus was unable to 
be reached for measures of communication (where multiple measures exist) or patient-
reported satisfaction with treatment or impact of treatment (where no measures exist).   
Discussion: Harmonisation of the ROMA COS with other core outcome initiatives in stroke 
rehabilitation is discussed.  Ongoing research and consensus processes are outlined.  
Conclusion: The WAB-R, GHQ, and SAQOL-39 are recommended to be routinely included 
within phase I-IV aphasia treatment studies. This consensus statement has been endorsed by 
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the Collaboration of Aphasia Trialists, the British Aphasiology Society, the German Society 
for Aphasia Research and Therapy, and the Royal College of Speech Language Therapists. 
 
A core outcome set for aphasia treatment research: the ROMA consensus statement 
The Research Outcome Measurement in Aphasia (ROMA) consensus statement provides 
recommendations for a core outcome set (COS) for use in aphasia treatment studies. A COS 
is a minimum set of outcomes that should be measured and reported in research trials of a 
specific health condition or population (1). The use of a COS does not preclude the 
measurement of additional outcomes, but rather represents the minimum outcomes that 
should be collected and reported (2). A COS for aphasia was developed in response to a trend 
of heterogeneous outcome measurement in research and the merits of this initiative were 
debated in a published forum in 2014 (3-7). The ROMA consensus statement was informed 
by a four-year program of research in three phases: (1) investigation of stakeholder-important 
outcomes using consensus processes (8-11); (2) a scoping review to identify aphasia outcome 
measurement instruments (OMIs) and their psychometric properties (12); and (3) an 
international consensus meeting (results reported herein). The ROMA COS is intended to 
complement other existing and ongoing initiatives to standardise the measurement of stroke 
recovery (13-15).  
Objective  
The ROMA consensus statement provides evidence-based recommendations for the 
measurement of outcomes for adults with post-stroke aphasia within phase I-IV aphasia 
treatment studies. 
Target users 
The primary users of this consensus statement will be researchers involved in the design and 
conduct of aphasia treatment studies. 
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Methods 
The research methods are based on the recommendations of the Core Outcome Measures in 
Effectiveness Trials (COMET) Initiative (2, 16) and are reported in alignment with the COS-
STAR (Core Outcome Set-STAndards for Reporting) statement (17). The World Health 
Organization International Classification of Functioning, Disability and Health (ICF) (18) has 
been used as a conceptual framework and classification tool. This project is registered with 
the COMET Initiative (http://www.comet-initiative.org/studies/details/287).  
Stage 1: Identification of Core Outcome Constructs 
Outcome constructs were derived from three separate stakeholder consensus studies 
conducted with: people with aphasia and their families (9); aphasia clinicians and managers 
(8); and aphasia researchers (10).  Outcomes prioritised by stakeholder groups were 
integrated using the framework of the ICF (19). Essential constructs were identified as: 
Language, communication, patient-reported satisfaction with treatment and impact of 
treatment, emotional wellbeing, and quality of life (11). 
Stage 2: Identification of Outcome Measurement Instruments 
A scoping review was conducted to identify OMIs which have been validated with people 
with aphasia. Primary searches were run using PUBMED, EMBASE, and CINAHL databases 
on 10 November 2015. The search strategy incorporated filters developed for the 
identification of studies reporting the measurement properties of health OMIs (see 20 and 
supplementary file). Inclusion criteria required that studies focused on the psychometric 
properties of measurement instrument and included participants with aphasia or stroke 
patients where participants with aphasia were not specifically excluded. Studies reporting 
measurement instruments which primarily measure neurological function associated with, but 
not central to aphasia: e.g., consciousness; health; motor speech; cognition; memory; were 
excluded. Secondary searches were conducted for each OMI identified in the first search. In 
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total, 184 references for 79 measurement instruments were identified (12). No measures of 
patient-reported treatment impact or patient-reported satisfaction were identified through this 
search.  
Stage 3. Formation of Consensus Panel  
Researchers who participated in the first phase of this project (n=80) (10) were invited to 
participate in the final consensus meeting. These researchers were purposively sampled from 
researchers whose trials were included with the Cochrane Collaboration review of "Speech 
and language therapy for aphasia following stroke"(21) and the 100 most highly published 
aphasia treatment researchers in the Web of Science database. In total, 23 researchers 
participated in a consensus meeting in London, UK (December, 2016).  Panel members were 
experienced researchers with expertise in: the design and conduct of aphasia trials; 
measurement instrument development and testing; and clinical guidelines development (see 
table 1 and supplementary table 1). Authors Wallace, Worrall, Le Dorze and T. Rose 
facilitated the COS development process and did not participate in COS voting. 
Table 1 
Characteristics of researchers who participated in the international consensus panel 
(n=23) 
Panel Characteristics n (%) 
Country  
    United Kingdom 9 (39) 
    United States of America 6 (26) 
    Australia 3 (13) 
    Canada 2 (9) 
    Germany 1 (4) 
    Sweden 1 (4) 
    Ireland 1 (4) 
ICF component to which their own research relates (panel  
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members could nominate more than one component) 
   Body functions 16 
   Activity/Participation 21 
   Environmental factors 10 
   Personal factors 15 
   Quality of life* 12 
Number of treatment studies published by participants  
   1 2 
   2-5 8 
   6-10 4 
   more than 10 7 
   not specified 2 
*nb. Quality of life is not defined as a component of the ICF 
 
Stage 4. International Consensus Meeting 
Ethical approval for the consensus meeting was gained from the Behavioural and Social 
Sciences Ethical Review Committee at The University of Queensland, Australia. The 
following process was used:  
Prior to meeting 
(1) Panel members generated consensus-based criteria to enable an initial reduction of OMIs 
(see table 2).  
(2) The consensus-based criteria were applied to the list of OMIs identified in the stage 2 
scoping review (n=79) to produce a short-list (n=50) (see supplementary table 2).   
(3) Panel members generated consensus-based feasibility criteria (see table 3). 
(4) The short-listed OMIs (see supplementary table 2) were assigned to panel members, who 
reviewed OMI feasibility and measurement properties prior to the consensus meeting.   
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During the meeting 
(1) Panel members engaged in a whole-group discussion using an iterative process to apply 
feasibility criteria and eliminate OMIs.  
(2) Panel members divided to smaller groups to review the measurement properties for each 
OMI in the target population (people with aphasia). Properties considered included: 
acceptability/feasibility of use with people with aphasia, reliability (test-retest, inter- and 
intra- as applicable), construct validity, and sensitivity to change.  
(3) Each small group recommended two OMIs for voting. Panel members voted YES/NO for 
each OMI in a closed voting process with consensus defined a priori as agreement on 
each OMI for each outcome construct by ≥ 70% of meeting participants, as suggested by 
the COMET initiative and GRADE working group (2). Potential conflicts of interest were 
managed through agreement that authors of OMIs under consideration could not 
participate in voting for that construct area.   
Table 2 
Criteria for initial reduction of outcome measurement instruments 
Measures were excluded if: 
1. The purpose of the measurement instrument was to screen for the presence of aphasia, 
rather than to measure outcomes. 
2. The measurement instrument was published more than thirty years ago (i.e., prior to 
1986) without subsequent revision and/or was not in current use. 
3. The measurement instrument targeted only one severity level of aphasia.  
4. For measures of language: the measurement instrument did not assess all modalities of 
language (e.g. reading only, writing only, comprehension only, verbal output only).  
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Table 3 
Feasibility criteria  
1. Availability in different languages or ease of translation/adaptation. 
2. Cost. 
3. Burden to respondents or researchers (ease of administration, length of outcome 
measurement instrument, completion time). 
4. Ease of score calculation and provision of an aggregate score. 
 
 
Results  
After compilation of votes, panel members reached consensus for measures of language, 
emotional wellbeing, and quality of life (refer to table 4). A consensus of ≥ 70% was not 
reached for a measure of communication.  Inability to gain consensus on a measure of 
communication may relate to the multi-factorial nature of this construct, as well a lack of 
understanding and consensus around how ‘effective communication’ is best operationalised 
in treatment research.  
 
Table 4 
Results of final voting to decide core outcome measurement instruments 
Construct Measure* Votes for 
inclusion 
Language The Western Aphasia Battery Revised (WAB-R)  74% (n=17) 
 The Comprehensive Aphasia Test (CAT) 22% (n=5) 
 Neither 4% (n=1) 
Communication The Scenario Test 57% (n=13) 
 The Communication Effectiveness Index (CETI) 39% (n=9) 
 Abstained 4% (n=1) 
Emotional well-
being 
General Health Questionnaire (GHQ)-12  83% (n=19) 
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 Stroke Aphasic Depression Questionnaire (SADQ) 17% (n=4) 
Quality of life Stroke and Aphasia Quality of Life Scale (SAQOL-
39)  
96% (n=22) 
 Burden of Stroke Scale (BOSS) 0% (n=0) 
 Abstained 4% (n=1) 
Bolded figures indicate consensus criteria (≥70%) reached and OMI included in COS 
*Refer to supplementary tables 3 & 4 for OMI characteristics, properties and references. 
 
Recommendations 
It is recommended that the WAB-R, GHQ-12 and SAQOL-39 be included as core outcome 
measurement instruments in phase I-IV aphasia treatment studies for adults with post-stroke 
aphasia. These outcome measurement instruments and their psychometric properties are 
described in supplementary tables 3 & 4.  
 
Discussion 
The importance of implementing standardised approaches to outcome measurement in 
research trials is increasing acknowledged. In the field of stroke rehabilitation, the Stroke 
Recovery and Rehabilitation Roundtable (SRRR) (13) have provided consensus-based core 
recommendations for the measurement of sensorimotor recovery after stroke. Other 
initiatives have addressed the measurement of stroke outcomes in clinical practice (15) and 
there are ongoing works to standardise measures in arm rehabilitation trials after stroke (14). 
The ROMA COS has sought to provide recommendations specifically for the measurement of 
aphasia recovery post-stroke. Accordingly, some frequently used measures of global 
disability and health-related quality of life (e.g., EQ-5D) which do not contain 
communication-specific items or which have not been validated with stroke survivors with 
aphasia were not considered within this process. The ROMA COS seeks to harmonise with 
other existing stroke rehabilitation initiatives in addressing the need for standardised 
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approaches to research trial outcomes measurement and its supplementary use may therefore 
be considered in any stroke study where people with aphasia are included.   
 
Future Directions 
The ROMA COS will be reviewed biennially. The next consensus meeting will focus on 
measures of communication and consider the development of measures of patient-reported 
satisfaction with treatment / impact of treatment. Factors relating to international COS 
implementation will be considered. New publications, initiatives and user feedback will also 
be considered in each review to: align this COS with other COSs; consider new OMIs; and to 
review the choice of OMIs based on user feedback. 
 
Limitations 
Participants in the international consensus meeting were predominately from English 
speaking countries. This may have impacted the consensus process and findings. Future 
meetings will seek to increase the diversity of participants with respect to cultural and 
linguistic background.  
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